Skip to main content
About
Overview
Leadership
Collaborations
Careers & Culture
Contact
Computational Discovery
Pipeline
Overview
COM701/Anti-PVRIG antibody
COM902/TIGIT antibody
COM503/Anti-IL-18BP antibody
BAPTOTULIMAB/Anti-ILDR2 antibody
Early Stage Pipeline
RILVEGOSTOMIG/Anti-PD1/TIGIT bispecific antibody
Clinical Trials
Investors
Publications
Event Details
Overview
News Media and Events
News
Media Center
Events
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
Quarterly Results and Annual Reports
SEC Filings
Governance
Governance Documents
Leadership
Committee Composition
Resources
Investor FAQs
Information Request Form
Investor Emails Alerts
Corporate Presentation
Compugen Third Quarter 2021 Conference Call
November 12, 2021 8:30 AM ET
Webcast
(opens in new window)
Q3 2021 Slides
(opens in new window)
SITC Triple Combination Dose Escalation Study-Poster
(opens in new window)
SITC COM902 Monotherapy Dose Escalation Study-Poster
(opens in new window)
SITC PVRIG Translational Data-Poster
(opens in new window)
SITC Triple Combination Dose Escalation Study- Poster Video
(opens in new window)
SITC COM902 Monotherapy Dose Escalation Study- Poster Video
(opens in new window)
SITC PVRIG Translational Data- Poster Video
(opens in new window)